These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children. Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276 [TBL] [Abstract][Full Text] [Related]
6. Studies on the development of a live attenuated mumps virus vaccine. II. Development and evaluation of the live "Hoshino" mumps vaccine. Makino S; Yamane Y; Sasaki K; Nagashima T; Higashihara M Kitasato Arch Exp Med; 1976 Jun; 49(1-2):53-62. PubMed ID: 1025341 [No Abstract] [Full Text] [Related]
7. Pregnancy complicated by accidental rubella vaccination. Allan BC; Hamilton SM; Wiemers MA; Winsor H; Gust ID Aust N Z J Obstet Gynaecol; 1973 May; 13(2):72-6. PubMed ID: 4518718 [No Abstract] [Full Text] [Related]
9. Studies on the development of a live attenuated mumps virus vaccine. I. Attenuation of the Hoshino "wild" strain of mumps virus. Sasaki K; Higashihara M; Inoue K; Igarashi Y; Makino S Kitasato Arch Exp Med; 1976 Jun; 49(1-2):43-52. PubMed ID: 828947 [No Abstract] [Full Text] [Related]
10. Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells. Glück R; Hoskins JM; Wegmann A; Just M; Germanier R Dev Biol Stand; 1986; 65():29-35. PubMed ID: 3556774 [TBL] [Abstract][Full Text] [Related]
12. Aseptic meningitis after vaccination against measles and mumps. Cizman M; Mozetic M; Radescek-Rakar R; Pleterski-Rigler D; Susec-Michieli M Pediatr Infect Dis J; 1989 May; 8(5):302-8. PubMed ID: 2726323 [TBL] [Abstract][Full Text] [Related]
13. [Vaccination against epidemic parotitis]. Midulla M; Chiavelli S Pediatr Med Chir; 1984; 6(1):25-30. PubMed ID: 6442412 [TBL] [Abstract][Full Text] [Related]
14. 'Atypical' mumps may occur after immunization. Gunby P JAMA; 1980 Jun; 243(23):2374-5. PubMed ID: 7373808 [No Abstract] [Full Text] [Related]
15. Studies on live attenuated mumps vaccine. II. Follow-up study on the efficacy of Biken Vaccine. Isomura S; Ozaki T; Morishima T; Nagayoshi S; An S Biken J; 1976 Sep; 19(3):115-8. PubMed ID: 1016214 [TBL] [Abstract][Full Text] [Related]
16. Undesirable properties of rubella vaccines with special reference to their use in women of fertile age. Vaheri A Scand J Infect Dis; 1972; 6():Suppl 6:24-7. PubMed ID: 4570530 [No Abstract] [Full Text] [Related]
17. Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus. Atrasheuskaya AV; Neverov AA; Rubin S; Ignatyev GM Vaccine; 2006 Mar; 24(10):1530-6. PubMed ID: 16266774 [TBL] [Abstract][Full Text] [Related]
18. [Complications after preventive mumps vaccination in West Germany (including multiple preventive vaccinations)]. Ehrengut W; Zastrow K Monatsschr Kinderheilkd; 1989 Jul; 137(7):398-402. PubMed ID: 2571926 [TBL] [Abstract][Full Text] [Related]
19. Differences in antibody response induced by formaldehyde inactivated and live mumps vaccines. Penttinen K; Helle EP; Norrby E Dev Biol Stand; 1979; 43():265-8. PubMed ID: 391631 [No Abstract] [Full Text] [Related]
20. Development of an attenuated mumps virus vaccine. II. Immune response of animals to vaccination with inactivated and live attenuated mumps viruses. Shramek G; Deinhardt F J Immunol; 1969 Apr; 102(4):1093-8. PubMed ID: 5768187 [No Abstract] [Full Text] [Related] [Next] [New Search]